FindTrial
Sign In

Sarcopenia,Non sarcopenia

3 trials

Sponsors

Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Khon Kaen university, Department of social medicine Khon Kaen Hospital

Conditions

Chronic stroke patients onset above 6 month with age above 40 years sarcopenia prevalence sarcopenia sarcopenia in stroke stroke related sarcopeniaSarcopenia 1.Sarcopenia 2.SARC F questionnaire 3. SARC CalF questionnaireSarcopenia is characterized by a decline in both muscle quantity and quality, along with impaired function. Sarcopenia can be considered one of the complications associated with diabetes. Poor glycemic control in diabetes can contribute to the development and progression of sarcopenia, leading to muscle mass loss and impaired muscle function. The prevalence of sarcopenia in Type 2 diabetes mellitus (T2DM) varies widely, ranging from 7% to 29.3% across different populations. Diabetic sarcopenia i

Unknown Phase

Validity of the Modified SARC-F Questionnaire Combined with Calf Circumference (Chula Sarcopenia Test) as a Screening Tool for Sarcopenia in Older Adults
Active, not recruitingTCTR20210127004
Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn UniversitySarcopenia 1.Sarcopenia 2.SARC F questionnaire 3. SARC CalF questionnaire
Start: 2021-02-15Target: 293Updated: 2026-08-03
Prevalence and factors associated with sarcopenia in stroke patients
RecruitingTCTR20210201004
Khon Kaen universityChronic stroke patients onset above 6 month with age above 40 years sarcopenia prevalence sarcopenia sarcopenia in stroke stroke related sarcopenia
Start: 2020-09-27Target: 98Updated: 2026-08-03
Validation of SARC-F and Modified SARC-F for Assessing Sarcopenia in Older Adults with Diabetes
Active, not recruitingTCTR20260511010
Department of social medicine Khon Kaen HospitalSarcopenia is characterized by a decline in both muscle quantity and quality, along with impaired function. Sarcopenia can be considered one of the complications associated with diabetes. Poor glycemic control in diabetes can contribute to the development and progression of sarcopenia, leading to muscle mass loss and impaired muscle function. The prevalence of sarcopenia in Type 2 diabetes mellitus (T2DM) varies widely, ranging from 7% to 29.3% across different populations. Diabetic sarcopenia i
Start: 2026-05-15Target: 104Updated: 2026-08-03